173 related articles for article (PubMed ID: 31588830)
1. Autoantibodies as biomarkers for colorectal cancer: A systematic review, meta-analysis, and bioinformatics analysis.
Wang H; Li X; Zhou D; Huang J
Int J Biol Markers; 2019 Dec; 34(4):334-347. PubMed ID: 31588830
[TBL] [Abstract][Full Text] [Related]
2. Serum tumor-associated autoantibodies as diagnostic biomarkers for lung cancer: A systematic review and meta-analysis.
Tang ZM; Ling ZG; Wang CM; Wu YB; Kong JL
PLoS One; 2017; 12(7):e0182117. PubMed ID: 28750095
[TBL] [Abstract][Full Text] [Related]
3. Autoantibody detection to tumor-associated antigens of P53, IMP1, P16, cyclin B1, P62, C-myc, Survivn, and Koc for the screening of high-risk subjects and early detection of esophageal squamous cell carcinoma.
Zhou SL; Yue WB; Fan ZM; Du F; Liu BC; Li B; Han XN; Ku JW; Zhao XK; Zhang P; Cui J; Zhou FY; Zhang LQ; Fan XP; Zhou YF; Zhu LL; Liu HY; Wang LD
Dis Esophagus; 2014; 27(8):790-7. PubMed ID: 24147952
[TBL] [Abstract][Full Text] [Related]
4. Anti-p53 autoantibody in blood as a diagnostic biomarker for colorectal cancer: A meta-analysis.
Liu S; Tan Q; Song Y; Shi Y; Han X
Scand J Immunol; 2020 Feb; 91(2):e12829. PubMed ID: 31536647
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of serum autoantibodies against tumor-associated antigens as biomarkers in lung cancer.
Li P; Shi JX; Xing MT; Dai LP; Li JT; Zhang JY
Tumour Biol; 2017 Oct; 39(10):1010428317711662. PubMed ID: 29022480
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Value of Autoantibodies in Lung Cancer: a Systematic Review and Meta-Analysis.
Qin J; Zeng N; Yang T; Wan C; Chen L; Shen Y; Wen F
Cell Physiol Biochem; 2018; 51(6):2631-2646. PubMed ID: 30562746
[TBL] [Abstract][Full Text] [Related]
7. Multi-panel assay of serum autoantibodies in colorectal cancer.
Ushigome M; Nabeya Y; Soda H; Takiguchi N; Kuwajima A; Tagawa M; Matsushita K; Koike J; Funahashi K; Shimada H
Int J Clin Oncol; 2018 Oct; 23(5):917-923. PubMed ID: 29691673
[TBL] [Abstract][Full Text] [Related]
8. Blood autoantibodies against tumor-associated antigens as biomarkers in early detection of colorectal cancer.
Chen H; Werner S; Tao S; Zörnig I; Brenner H
Cancer Lett; 2014 May; 346(2):178-87. PubMed ID: 24462820
[TBL] [Abstract][Full Text] [Related]
9. Detection of autoantibodies to a panel of tumor-associated antigens for the diagnosis values of gastric cardia adenocarcinoma.
Zhou SL; Ku JW; Fan ZM; Yue WB; Du F; Zhou YF; Liu YL; Li Y; Tang S; Hu YL; Hu XP; Hou ZC; Liu J; Liu Y; Feng XS; Wang LD
Dis Esophagus; 2015; 28(4):371-9. PubMed ID: 24612004
[TBL] [Abstract][Full Text] [Related]
10. Development of a panel of serum IgG and IgA autoantibodies for early diagnosis of colon cancer.
Chen M; Lin X; Zhang L; Yu L; Wu Q; Zhang S; Xue F; Huang Y
Int J Med Sci; 2020; 17(17):2744-2750. PubMed ID: 33162802
[No Abstract] [Full Text] [Related]
11. Using a panel of multiple tumor-associated antigens to enhance the autoantibody detection in the immunodiagnosis of ovarian cancer.
Wang P; Qin J; Ye H; Li L; Wang X; Zhang J
J Cell Biochem; 2019 Mar; 120(3):3091-3100. PubMed ID: 30484895
[TBL] [Abstract][Full Text] [Related]
12. Discovering Panel of Autoantibodies for Early Detection of Lung Cancer Based on Focused Protein Array.
Jiang D; Zhang X; Liu M; Wang Y; Wang T; Pei L; Wang P; Ye H; Shi J; Song C; Wang K; Wang X; Dai L; Zhang J
Front Immunol; 2021; 12():658922. PubMed ID: 33968062
[TBL] [Abstract][Full Text] [Related]
13. Combined detection of serum autoantibodies as diagnostic biomarkers in esophagogastric junction adenocarcinoma.
Xu YW; Chen H; Guo HP; Yang SH; Luo YH; Liu CT; Huang XY; Tang XM; Hong CQ; Li EM; Xu LY; Peng YH
Gastric Cancer; 2019 May; 22(3):546-557. PubMed ID: 30426295
[TBL] [Abstract][Full Text] [Related]
14. Development of a multiplexed tumor-associated autoantibody-based blood test for the detection of colorectal cancer.
Fan CW; Kuo YB; Lin GP; Chen SM; Chang SH; Li BA; Chan EC
Clin Chim Acta; 2017 Dec; 475():157-163. PubMed ID: 29074220
[TBL] [Abstract][Full Text] [Related]
15. Prospective evaluation of 64 serum autoantibodies as biomarkers for early detection of colorectal cancer in a true screening setting.
Chen H; Werner S; Butt J; Zörnig I; Knebel P; Michel A; Eichmüller SB; Jäger D; Waterboer T; Pawlita M; Brenner H
Oncotarget; 2016 Mar; 7(13):16420-32. PubMed ID: 26909861
[TBL] [Abstract][Full Text] [Related]
16. Anti-FIRΔexon2, a splicing variant form of PUF60, autoantibody is detected in the sera of esophageal squamous cell carcinoma.
Kobayashi S; Hiwasa T; Ishige T; Rahmutulla B; Kano M; Hoshino T; Minamoto T; Shimada H; Nomura F; Matsubara H; Matsushita K
Cancer Sci; 2019 Jun; 110(6):2004-2013. PubMed ID: 30980774
[TBL] [Abstract][Full Text] [Related]
17. Tumour-Associated Autoantibodies as Diagnostic Biomarkers for Breast Cancer: A Systematic Review and Meta-Analysis.
Xia J; Shi J; Wang P; Song C; Wang K; Zhang J; Ye H
Scand J Immunol; 2016 Jun; 83(6):393-408. PubMed ID: 26991924
[TBL] [Abstract][Full Text] [Related]
18. Serum autoantibodies against a panel of 15 tumor-associated antigens in the detection of ovarian cancer.
Sun H; Shi JX; Zhang HF; Xing MT; Li P; Dai LP; Luo CL; Wang X; Wang P; Ye H; Li LX; Zhang JY
Tumour Biol; 2017 Jun; 39(6):1010428317699132. PubMed ID: 28618923
[TBL] [Abstract][Full Text] [Related]
19. Cancer-associated autoantibodies to MUC1 and MUC4--a blinded case–control study of colorectal cancer in UK collaborative trial of ovarian cancer screening.
Pedersen JW; Gentry-Maharaj A; Nøstdal A; Fourkala EO; Dawnay A; Burnell M; Zaikin A; Burchell J; Papadimitriou JT; Clausen H; Jacobs I; Menon U; Wandall HH
Int J Cancer; 2014 May; 134(9):2180-88. PubMed ID: 24122770
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of autoantibodies combined with tumor markers in the detection of lung cancer.
Mu Y; Li J; Xie F; Xu L; Xu G
J Clin Lab Anal; 2022 Aug; 36(8):e24504. PubMed ID: 35596744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
